- Home
- EM vs TNGX Comparison
EM vs TNGX Comparison
Compare EM & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- TNGX
- Stock Information
- Founded
- EM 2017
- TNGX 2014
- Country
- EM China
- TNGX United States
- Employees
- EM N/A
- TNGX N/A
- Industry
- EM Other Consumer Services
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- EM Consumer Discretionary
- TNGX Health Care
- Exchange
- EM Nasdaq
- TNGX Nasdaq
- Market Cap
- EM 298.5M
- TNGX 317.4M
- IPO Year
- EM 2021
- TNGX N/A
- Fundamental
- Price
- EM $1.07
- TNGX $1.29
- Analyst Decision
- EM
- TNGX Strong Buy
- Analyst Count
- EM 0
- TNGX 7
- Target Price
- EM N/A
- TNGX $12.33
- AVG Volume (30 Days)
- EM 160.0K
- TNGX 756.3K
- Earning Date
- EM 06-02-2025
- TNGX 05-07-2025
- Dividend Yield
- EM 2.44%
- TNGX N/A
- EPS Growth
- EM N/A
- TNGX N/A
- EPS
- EM 0.01
- TNGX N/A
- Revenue
- EM $261,961,935.00
- TNGX $42,069,000.00
- Revenue This Year
- EM N/A
- TNGX N/A
- Revenue Next Year
- EM $6.76
- TNGX N/A
- P/E Ratio
- EM $71.51
- TNGX N/A
- Revenue Growth
- EM N/A
- TNGX 15.17
- 52 Week Low
- EM $0.50
- TNGX $1.11
- 52 Week High
- EM $1.18
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- EM 44.64
- TNGX 37.63
- Support Level
- EM $1.02
- TNGX $1.25
- Resistance Level
- EM $1.13
- TNGX $1.44
- Average True Range (ATR)
- EM 0.04
- TNGX 0.15
- MACD
- EM -0.00
- TNGX 0.03
- Stochastic Oscillator
- EM 44.00
- TNGX 45.00
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.